Source: PMLiVE

Aiolos Bio: GSK to expand respiratory pipeline with $1.4bn Aiolos Bio acquisition

The deal includes a monoclonal antibody ready to enter phase 2 development for asthma

Read full article »
Aiolos Bio's Competitors | Aiolos Bio's News | Aiolos Bio's Financials
Stay up-to-date with the latest news on Aiolos Bio
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Khurem Farooq's photo - Co-Founder & CEO of Aiolos Bio

Co-Founder & CEO

Khurem Farooq

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Aiolos Bio